Brief Summary
Type:
Brain Tumors / Neurologic Cancers
Study Type:
Treatment
Phase:
II
ClinicalTrials.gov Identifier:
NCT02684058
Study #:
CMH - CDRB436G2201
Start Date:
Mar 14, 2018
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT02684058
View Complete Trial Details & Eligibility at ClinicalTrials.gov